96.71
0.00 (0.00%)
| Previous Close | 96.71 |
| Open | 96.74 |
| Volume | 79,501 |
| Avg. Volume (3M) | 379,846 |
| Market Cap | 3,166,343,424 |
| Price / Earnings (TTM) | 34.42 |
| Price / Earnings (Forward) | 19.34 |
| Price / Sales | 1.39 |
| Price / Book | 2.82 |
| 52 Weeks Range | |
| Earnings Date | 22 Oct 2024 - 28 Oct 2024 |
| Profit Margin | 4.02% |
| Operating Margin (TTM) | 10.85% |
| Diluted EPS (TTM) | 2.81 |
| Quarterly Revenue Growth (YOY) | 6.90% |
| Total Debt/Equity (MRQ) | 40.26% |
| Current Ratio (MRQ) | 1.16 |
| Operating Cash Flow (TTM) | 96.23 M |
| Levered Free Cash Flow (TTM) | 130.74 M |
| Return on Assets (TTM) | 6.38% |
| Return on Equity (TTM) | 8.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Amedisys Inc | Mixed | Mixed |
Stockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -5.0 |
| Technical Oscillators | -2.0 |
| Average | -1.88 |
|
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 2.29% |
| % Held by Institutions | 93.99% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 101.00 (Deutsche Bank, 4.44%) | Hold |
| 101.00 (Cantor Fitzgerald, 4.44%) | Hold | |
| Median | 101.00 (4.44%) | |
| Average | 101.00 (4.44%) | |
| Total | 2 Hold | |
| Avg. Price @ Call | 97.90 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Deutsche Bank | 31 Jul 2024 | 101.00 (4.44%) | Hold | 98.05 |
| Cantor Fitzgerald | 25 Jul 2024 | 101.00 (4.44%) | Hold | 97.75 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 25 Sep 2024 | Announcement | Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards |
| 21 Aug 2024 | Announcement | Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model |
| 24 Jul 2024 | Announcement | Amedisys Reports Second Quarter 2024 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |